SHINKO HOSPITAL

Name

SHINKO HOSPITAL

Legal name

社会医科大学神鋼記念会 神鋼記念病院 (Social Medical Corporation Shinkohpf Inc. Shinko Hospital)

Website

https://shinkohp.jp

Company type

Private

Founded year

1915

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Acute-Care Hospital Services

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Transplant Specialty Hospitals (HLAFAHAE)

Keywords

• Acute care hospital
• Cancer treatment center
• Neurosurgery services
• Hematology transplant
• Palliative care services

Headquarters

HQ city

Ashiya

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Pricing tiers

Distribution channels4 records

Marketing channels5 records

Core offering

Shinko Hospital is a general acute-care hospital providing multi-specialty inpatient and outpatient medical services across 25+ departments, with particular specialization in cancer diagnosis and treatment, minimally invasive and robotic surgery, advanced neurosurgery, and hematopoietic stem cell transplantation. The hospital is a nationally designated Regional Cancer Treatment Coordination Hub Hospital and operates dedicated Cancer Treatment, Hematology, Palliative Care, and Health Management Centers. Services are delivered under Japan's national health insurance system, supplemented by self-pay second opinion consultations and health screening services at affiliated clinics.

Product overview

Shinko Hospital (神鋼記念病院) is a comprehensive medical institution offering a wide range of healthcare services through multiple specialized departments and centers. The hospital operates as a regional cancer treatment hub with integrated services including cancer treatment, palliative care, hematology, neurosurgery, and health screening. Key centers include the Cancer Treatment Center (がん診療センター) providing integrated cancer care from diagnosis through surgery, chemotherapy, and palliative care; the Hematology Center (血液病センター) with stem cell transplantation capabilities; the Palliative Care Center (緩和ケアセンター); and the Comprehensive Medical Research Center (総合医学研究センター). The hospital also operates residency training programs and utilizes advanced technologies including da Vinci robotic surgery and KINEVO900 surgical microscope.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Treatment Center (がん診療センター) A comprehensive cancer care service providing diagnosis, surgery, chemotherapy, radiation therapy, and palliative care for gastrointestinal, lung, breast, kidney, and prostate cancers, available to patients referred via the Regional Medical Coordination Office.
• Hematology Center (血液病センター) A hematology service treating benign blood disorders and hematologic malignancies, with stem cell transplantation capabilities and 19 sterile rooms.
• Palliative Care Center (緩和ケアセンター) A specialized palliative care service providing symptom relief and end-of-life care with two palliative care specialists and psychiatric support.
• Cancer Consultation Support Center (がん相談支援センター) A consultation service for cancer patients and families, staffed by certified cancer nursing specialists and medical social workers, providing counseling and support from diagnosis onward.
• Neurosurgery Department Services (脳神経外科) Neurosurgical services for brain tumors, unruptured cerebral aneurysms, cerebral infarction, and spinal diseases, using the KINEVO900 surgical microscope for advanced procedures.
• Breast Surgery Services (乳腺科) Specialized breast cancer treatment service that performs the highest number of breast surgeries in Hyogo Prefecture, with on-site breast pathologists and difficult cases referred from the broader Kansai region.
• da Vinci Robotic Surgery (ダヴィンチ.robot) Robotic-assisted surgery service used for prostate, kidney, rectal, and lung procedures, enabling minimally invasive operations.
• Extracorporeal Photopheresis (ECP) (体外フォトフェレーシス) Treatment service for chronic graft-versus-host disease (GVHD) offered through the Hematology Department.
• Health Management Center Services (健康管理センター / Health Checkups & Human Dock) Preventive health screening services including comprehensive medical examinations (human dock) and health checkups, also offered through affiliated clinics (新神戸ドック健診クリニック and 灘ドック健診クリニック).
• Second Opinion Consultation Service (自費セカンドオピニオン) Self-pay second opinion consultations offered across 10 medical departments at 10,000 JPY per 30-minute session (excluding tax), with 5,000 JPY per additional 15-minute extension; not covered by insurance.
• Cancer Genomic Medicine Services (がんゲノム医療連携) Certified cancer genome testing and genomic medicine coordination service, including Cancer Genome Consultation Room counseling for patients and families.
• Autologous Tissue Breast Reconstruction (自家組織乳房再建術) Immediate breast reconstruction surgery using the patient's own tissue, performed in collaboration with the plastic surgery department as part of breast cancer care.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Kobe Red Cross HospitalminorStrategic or Co-development Partner · 1 January 2023For gynecological cancers (uterine, ovarian) not treated at Shinko Hospital, patients are referred to Kobe Red Cross Hospital and Kobe City Medical Center Central Hospital through the regional medical coordination office.
• Shinkokai Medical Group (社会医療法人神鋼記念会)coreStrategic or Co-development Partner · 1 January 2023Shinko Hospital is the core hospital of the Shinkokai (社会医療法人神鋼記念会) medical group, which includes affiliated health screening clinics (新神戸ドック健診クリニック and 灘ドック健診クリニック).
• Kobe City Medical Center Central HospitalcoreStrategic or Co-development Partner · 1 April 2021As a nationally designated Regional Cancer Treatment Coordination Hub Hospital, Shinko works alongside Kobe City Medical Center Central Hospital, Kobe University Hospital, and Kobe City Nishi-Kobe Medical Center as the 4 designated cancer hub hospitals in the Kobe medical圏域.
• Kobe University School of Medicine (神戸大学医学部附属病院)coreStrategic or Co-development Partner · 1 April 2021One of the 4 designated cancer hub hospitals in the Kobe medical圏域, collaborating in cancer care delivery and clinical research within the regional cancer care network.
• Kobe City Nishi-Kobe Medical Center (神戸市立西神戸医療センター)coreStrategic or Co-development Partner · 1 April 2021One of the 4 designated cancer hub hospitals in the Kobe medical圏域, collaborating in cancer care delivery and clinical research within the regional cancer care network.
• Kobe City Medical Center Central HospitalminorStrategic or Co-development Partner · 1 April 2021Referral destination for rare cancers not treated at Shinko Hospital and for certain gynecological cancers (uterine, ovarian).
• National Cancer Center Japan (国立がん研究センター)minorStrategic or Co-development Partner · 1 April 2021Rare cancers not treated at Shinko Hospital are referred to the National Cancer Center's Rare Cancer Center. National Cancer Center is also the recipient of hospital cancer registry data for national aggregation.
• National Clinical Database (NCD) — related medical societiesminorOthers · 1 April 2021The hospital participates in the NCD (National Clinical Database) project, contributing gastrointestinal surgery and cardiovascular case data to a national database that supports quality improvement and medical research.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Kobe City Medical Center Central Hospital: Public general hospital and one of the 4 nationally designated Regional Cancer Treatment Coordination Hub Hospitals in the Kobe medical area alongside Shinko. Direct peer in oncology, emergency, and acute care services, and a referral destination for cases Shinko cannot handle.
• Kobe University Hospital: Academic medical center and fellow designated cancer hub in the Kobe area. Direct peer in oncology, neurosurgery, and advanced specialty care, with stronger research branding and a larger residency pipeline.
• Kobe City Nishi-Kobe Medical Center: Public hospital and the fourth designated cancer hub in the Kobe medical area. Direct peer in regional cancer care and acute services, competing for the same referral catchment.
• Kobe Red Cross Hospital: Major Kobe-area general hospital that receives Shinko's gynecological cancer referrals and overlaps in acute care, hematology, and emergency services. Direct regional competitor with overlapping patient populations.

Regional players

• Hyogo Prefectural Amagasaki General Medical Center: Major prefectural general hospital in Hyogo Prefecture serving a different part of the catchment. Comparable in scope (acute care, cancer, emergency) but geographically distinct from Shinko's Kobe focus.
• Sano Memorial Hospital: Private community hospital in Hyogo offering general acute and surgical services. Smaller-scale regional peer with overlapping outpatient and general surgery offerings but limited cancer specialization.
• Sakai City Medical Center: Public general hospital in neighboring Osaka Prefecture. Comparable in multi-specialty acute care and oncology services, but operates in a separate geographic market from Shinko's Kobe base.

Broad incumbents

• Kansai Medical University Hospital: Academic medical center in the broader Kansai region offering overlapping oncology, hematology, and advanced surgical capabilities. Broader regional incumbent competing for complex cases referred from across Kansai.
• Hyogo Cancer Center: Prefectural cancer specialty hospital in Hyogo. Comparable in oncology focus and designation level but specialized exclusively in cancer, whereas Shinko offers multi-specialty breadth.
• National Cancer Center Japan: Japan's premier national cancer institution, which receives Shinko's rare cancer referrals. Functions as a broader national incumbent and upstream referral destination, with research capabilities far exceeding any regional peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SHINKO HOSPITAL